Table 1.

Demographic and treatment characteristics of studied patients treated for Hodgkin lymphoma.

Patient No.	Age at diagnosis, y	Sex	Stage	RT prescription dose, Gy (RBE)	Cumulative anthracycline dose, mg/m2	Mean heart RT dose, Gy (RBE)	Mean LAD RT dose, Gy (RBE)	Mean LV RT dose, Gy (RBE)	Mean RV RT dose, Gy (RBE)	Pretherapy LVEF TTE, %	LVEF on 5-y cardiac MRI, %	LVEF on 5-y TTE, %	5-y Pro-BNP, pg/mL
1	19	F	IIB	39.6a	350	19.7	32.2	10.1	27.9	60	53	50	182.4
2	25	F	IIB	36	300	13.8	33.4	20.1	12.4	72	61	60-65	95.4
3	40	F	IIB	30.6	175	2.1	9.0	0.1	0.5	54b	60	60-65	120.0c
4	37	M	IIB	36	200	10.1	2.9	2.1	3.4	51	52	55-60	29.1
5	22	M	IB	30.6	300	7.6	4.6	0.0	14.4	59d	54	50-55	22.0

Abbreviations: RT, radiotherapy; RBE, relative biological effectiveness; LAD, left anterior descending artery; LV, left ventricle; RV, right ventricle; LVEF, left ventricular ejection fraction; TTE, transthoracic echocardiogram; MRI, magnetic resonance imaging; BNP, brain natriuretic peptide; ABVD, doxorubicin, bleomycin, vinblastine, dacarbazine.

^aTreated with deep inspiration breath hold.

^bAfter third cycle of ABVD.

^cDrawn 6 y after treatment completion.

^dAfter sixth cycle of ABVD.